Actavis rejected the per se approach but held that these agreements could violate antitrust law and should be evaluated under the rule of reason [24]
Two people can use the same vial, the same dose, and the same schedule, yet get completely different outcomes
The "not localized to the injection site" part is important
The B12-conjugated GLP-1 agonist maintained comparable blood sugar control but with significantly better tolerance, less nausea, and fewer emetic episodes in both rat and mammalian models
Our findings unveil a remarkable survival advantage linked to the use of GLP-1 RAs among the included patients
Specifically, a diet that is low in fiber and high in animal fat can put you at risk of developing this potentially serious condition, according to the Mayo Clinic